FINWIRES · TerminalLIVE
FINWIRES

Nexi Shares Gain After State Investor CDP Equity Signals Planned Stake Raise

By
Nexi Shares Gain After State Investor CDP Equity Signals Planned Stake Raise

Nexi's (NEXI.MI) share price jumped more than 4% in early morning trading in Milan after Italian state-backed investor CDP Equity on Monday announced plans to increase its stake in the payments group to as much as 29.9%.

To execute the increase, the CDP Equity board approved a strategy to gain exposure to up to 8% of Nexi through derivative contracts that could later be converted into shares, subject to regulatory approvals. The investor may also acquire additional Nexi shares directly on the open market.

CDP Equity clarified that it does not intend to launch a tender offer for Nexi, describing the move instead as a sign of confidence in the company's "strong innovative and industrial growth." The investor highlighted Nexi's role in processing over 1.8 trillion euros in digital transactions across more than 25 countries, adding that the group could play "a key role in the European development of a technological infrastructure supporting the digitalization of money."

CDP Equity currently owns 19.14% of Nexi. According to the company's website, its largest shareholder is US private equity firm Hellman & Friedman, which holds a 22.23% stake.

Separately, the payments company has continued to attract interest from private equity company CVC Capital Partners (CVC.AS). London's Financial Times reported in late April that CVC was considering a 9 billion-euro takeover offer for Nexi. If pursued, it would be CVC's third attempt at purchasing the payments company.

Mediobanca Banca di Credito Finanziario, JPMorgan and PricewaterhouseCoopers Business Services are assisting CDP Equity as financial advisers for the deal, which remains subject to regulatory clearances.

Related Articles

Jardine Matheson Acquires Australian Imaging I-Med Radiology for AU$3.4 Billion
US Markets

Jardine Matheson Acquires Australian Imaging I-Med Radiology for AU$3.4 Billion

Jardine Matheson (SGX:J36) has agreed to fully acquire Australia-based I-Med Radiology Network for AU$3.4 billion as part of its strategy to invest in and control "high-quality businesses" in Asia Pacific.I-Med operates 215 diagnostic imaging clinics across Australia and New Zealand, according to a Monday filing with the Singapore Exchange.The Singapore-listed conglomerate will acquire the business from funds advised by private equity firm Permira.The transaction also includes I-Med's minority stake in Harrison.ai, a developer of AI radiology products.Jardines said the investment is also in line with its plans to expand into "strong growth verticals" such as healthcare diagnostics."As a long-term, committed investor, our goal is to build larger, high-quality businesses across our portfolio, and we look forward to supporting I-MED in the next phase of its growth. I-MED is already a market leader in radiology today, and we expect the business will expand further in I-MED's core markets as well asnew markets," said Jardines CEO Lincoln Pan.I-Med performs more than 7 million patient procedures annually. The imaging services provider has integrated AI medical technologies into its operations alongside its teleradiology system, which allows for the remote interpretation of medical images."We are looking forward to working with Jardines, well known as a long-term investor and owner in the region, to execute on our growth agenda," I-Med CEO Shrey Viranna said."This means continuing to deliver high-quality, expert diagnostic services for the benefit of patients while also enhancing our service offering, implementing AI solutions and exploring international growth opportunities."Jardines, an Asia-focused diversified investment company, has recently ramped up efforts to boost shareholder returns. In November 2025, the conglomerate launched a share buyback program expected to return approximately $250 million to its investors.This followed an October 2025 move to acquire the remaining outstanding shares of Mandarin Oriental International (SGX:M04), subsequently delisting the hotel group from the Singapore bourse.After facing headwinds from U.S. tariff hikes the previous year, Jardines rebounded to profitability for the full year 2025. The company posted a profit attributable to shareholders of $1.11 billion, a sharp recovery from the $468 million loss reported a year earlier.The I-Med acquisition is subject to customary closing conditions, including regulatory approvals, and is expected to be completed later this year, Jardines said.

$^AXJO$SGX:J36$SGX:M04
Wingtech Sues Nexperia for RMB 8 Billion, Seeks to Wrestle Back Control from Dutch Government
US Markets

Wingtech Sues Nexperia for RMB 8 Billion, Seeks to Wrestle Back Control from Dutch Government

Wingtech Technology (SHA:600745) has filed a lawsuit against Nexperia and other defendants as it seeks 8 billion yuan in damages and a restoration of control of its Dutch subsidiary, according to a Saturday filing with the Shanghai bourse.A court in Dongguan City, Guangdong, China, accepted the case, but the hearing has yet to start, Wingtech said in its filing.The Chinese parent company said the measures by the Dutch government against the Wingtech subsidiary constitute discriminatory behavior under China's anti-foreign sanctions law, Wingtech said in the filing.Wingtech also petitioned the Dutch government to revoke a ministerial order invoking the country's Cold War-era Goods Availability Act, even if the order is suspended, as the ruling remains in effect, the company said.Wingtech and another subsidiary, Yuching Holding, filed the complaint against respondents Nexperia Holding, Nexperia BV, Ruben Everard Gerard Lichtenberg, Achim Albert Kempe, Stefan Tilger, and ITEC.Should the defendants fail to comply, Wingtech will request the entire equity of Nexperia and related subsidiaries be transferred to the listed parent company free of charge, according to the filing.Wingtech earlier sought international arbitration to claim $8 billion in damages from the Dutch government's seizure of Nexperia, Reuters reported back in January.The Netherlands seized control of Nexperia from Wingtech under the Goods Availability Act back in September 2025 to ensure the availability of finished and semi-finished products during an emergency."It is not, and never has been, Nexperia's intention to harm the interests of Wingtech's shareholders, nor that of our customers and partners worldwide," Nexperia said in a statement released Friday.Nexperia said it started proceedings in October against Wingtech to stop "severe mismanagement" related to a conflict with suspended CEO Zhang Xuezheng.The Dutch government's announcement back then came after U.S. President Donald Trump expanded U.S. sanctions to include subsidiaries of blacklisted companies in sensitive industries, heightening further trade tensions between Washington and Beijing, Bloomberg reported separately in October 2025.Beijing's Commerce Ministry earlier slammed Nexperia in March for "severely" disrupting business operations by disabling employee accounts in China, while warning the Dutch side it will bear "full responsibility" should another chip crisis ensue.But days after, Beijing's tone became more conciliatory after the ministry said it is willing to iron out relations with the Netherlands.Commerce Minister Wang Wentao and Dutch Minister of Foreign Trade and Development Cooperation Sjoerd Sjoerdsma exchanged views on semiconductor trade in a meeting in Cameroon and also touched on the Nexperia issue, the ministry said.

$SHA:600745
China Proposes Fines For Futu, Tiger, Longbridge in Trading Crackdown
US Markets

China Proposes Fines For Futu, Tiger, Longbridge in Trading Crackdown

The China Securities Regulatory Commission (CSRC) has launched an investigation into three international securities brokers for operating without proper approvals, the regulator announced in a notice on Friday.The probe is part of China's two-year initiative to crack down on cross-border investment services conducted by overseas financial institutions.Tiger Brokers (NZ), Futu Securities International (Hong Kong), and Changqiao Securities (Hong Kong), also known as Longbridge, received administrative penalties for conducting securities trading within mainland China without the regulator's approval.In a statement, Futu disclosed that the CSRC proposed a 1.85 billion yuan fine against the company, along with a 1.25 million yuan penalty for its founder and CEO Li Hua. The broker added that it is cooperating with the regulator.Futu disclosed in 2022 that mainland Chinese customers accounted for 35% of its customer base, according to 36Kr.Tiger Brokers' Nasdaq-listed parent company, UP Fintech, said it was handed a potential 308.1 million yuan fine. The firm said it is cooperating with regulatory authorities, pledging to "strictly implement the rectification measures required."Longbridge also expressed its willingness to comply with rectification measures imposed by the CSRC, but did not disclose the details of its penalties, Reuters reported.The CSRC said it is partnering with eight other government departments to ban illegal cross-border business activities conducted by foreign entities.The regulator emphasized that it will enforce strict regulatory requirements that have "teeth and barbs," maintaining clear legal boundaries.Jefferies said in a note to clients on Friday that the CSRC's announcement provided detailed guidelines on how the crackdown will be implemented, particularly regarding the penalized firms."During the rectification period, overseas institutions are prohibited from providing illegal buy trades or fund inflows to existing investors within the mainland," Jefferies said."After the rectification period ends, overseas institutions must fully shut down domestic websites, trading software and supporting servers, and are prohibited from providing illegal trading and related services to existing investors within the mainland.

$^SSEC$^SZSE